Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05226117
Title Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele
Indications

transitional cell carcinoma

Therapies

Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.